During the corresponding time, Aquestive Therapeutics Inc recorded a revenue increase by 38.15 % year on year, sequentially revenue fell by -4.34 %. While revenue at the Aquestive Therapeutics Inc 's corporate clients
Aquestive Therapeutics Inc's Comment on Sales, Marketing and Customers
Pharmaceutical companies are subject to regulatory scrutiny concerning the reporting of prices, marketing, and promotion of their products. Relevant laws include the Federal False Claims Act, the Health Insurance Portability and Accountability Act (HIPAA), and various state regulations that govern marketing practices, pricing disclosures, and compliance programs. Key market segments affected by these regulations include federal healthcare programs, private third-party payors, individual healthcare practitioners such as physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, certified nurse-midwives, and teaching hospitals. States with specific regulatory requirements include California, Connecticut, Nevada, Massachusetts, and the District of Columbia.
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pioneering pharmaceutical company dedicated to delivering impactful advancements in patient care through innovative science and advanced delivery technologies, has announced its participation in the 76th Annual Meeting of the American Academy of Neurology (AAN). The event, scheduled to take place from April 13 to 18 in Denver, will offer both in-person attendance and live online participation through a hybrid format. During this significant gathering of neurology professionals, Aquestive will present a poster highlighting the promising results of its crossover study for the product candidate, Libervant (diazepam) Buccal Film, aimed at children aged two to five s...
Aquestive Therapeutics Inc’s Comment on Sales, Marketing and Customers
Pharmaceutical companies are subject to regulatory scrutiny concerning the reporting of prices, marketing, and promotion of their products. Relevant laws include the Federal False Claims Act, the Health Insurance Portability and Accountability Act (HIPAA), and various state regulations that govern marketing practices, pricing disclosures, and compliance programs. Key market segments affected by these regulations include federal healthcare programs, private third-party payors, individual healthcare practitioners such as physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, certified nurse-midwives, and teaching hospitals. States with specific regulatory requirements include California, Connecticut, Nevada, Massachusetts, and the District of Columbia.
Sources:
Aquestive Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Aquestive Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Aquestive Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
204.54 %